Dose-Response Relationship, DrugTime FactorsAntineoplastic AgentsAntineoplastic Combined Chemotherapy ProtocolsDoxorubicinEmployer Health CostsCisplatinNeoplasmsChemotherapy, AdjuvantEtoposideDrug Resistance, NeoplasmPrescription FeesDrug Delivery SystemsCell Line, TumorDrug Administration ScheduleCell SurvivalAntineoplastic Agents, PhytogenicPaclitaxelTreatment OutcomeDrug Screening Assays, AntitumorBreast NeoplasmsApoptosisCombined Modality TherapyPhotochemotherapyPhotosensitizing AgentsFluorouracilPharmaceutical PreparationsOvarian NeoplasmsCyclophosphamideAdministration, OralMisonidazoleTumor Cells, CulturedClinical Trials, Phase I as TopicDose-Response Relationship, RadiationDouble-Blind MethodNitroimidazolesNeoadjuvant TherapyDisease-Free SurvivalCell ProliferationGene Expression Regulation, NeoplasticOxytropisLung NeoplasmsSurvival AnalysisNeoplasm StagingRadiation-Sensitizing AgentsDrug CarriersSurvival RatePrognosisProspective Studies